| scholarly article | Q13442814 |
| P50 | author | Jane-Lise Samuel | Q42474548 |
| P2093 | author name string | Duriez M | |
| Levy BI | |||
| Caputo L | |||
| Henrion D | |||
| Poitevin P | |||
| Benessiano J | |||
| Heymes C | |||
| P2860 | cites work | Angiotensin II type 2 receptor mediates programmed cell death | Q28272739 |
| Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta | Q30434958 | ||
| Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells | Q30462210 | ||
| Angiotensin stimulation of bovine adrenocortical cell growth | Q35052581 | ||
| Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. | Q35605118 | ||
| The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells | Q38299038 | ||
| Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction | Q40341321 | ||
| Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, protects in vitro carbachol-induced vasorelaxation in a rat model of vascular calcium overload | Q42709384 | ||
| Angiotensin II: hemodynamic regulator or growth factor? | Q44693581 | ||
| Role of angiotensin subtype 2 receptor in neointima formation after vascular injury | Q44979985 | ||
| Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. | Q46990366 | ||
| Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes | Q48710301 | ||
| Proposed update of angiotensin receptor nomenclature | Q48791533 | ||
| Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). | Q48865577 | ||
| Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats. Role of endothelium and flow | Q49133994 | ||
| Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. | Q49145931 | ||
| Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements. | Q50797074 | ||
| Effect of chronic dihydropyridine (isradipine) on the large arterial walls of spontaneously hypertensive rats. | Q51617626 | ||
| Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. | Q51770170 | ||
| Instantaneous aortic blood flow measurement with range-gated Doppler flowmeter in anesthetized rat. | Q51822918 | ||
| Angiotensin-II receptor subtypes in fetal tissue of the rat: autoradiography, guanine nucleotide sensitivity, and association with phosphoinositide hydrolysis. | Q52049510 | ||
| Mathematical morphologic analysis of the aortic medial structure. Biomechanical implications. | Q52398759 | ||
| Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system. | Q54201733 | ||
| Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging | Q56554483 | ||
| Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats | Q67764474 | ||
| Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs | Q67773801 | ||
| Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells | Q67909923 | ||
| Reversal of low dose angiotension hypertension by angiotensin receptor antagonists | Q67926532 | ||
| Differential regulation of angiotensin peptide levels in plasma and kidney of the rat | Q68265478 | ||
| Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats | Q68469007 | ||
| Central and peripheral actions of a nonpeptidic angiotensin II receptor antagonist | Q68516435 | ||
| Novel sites of expression of functional angiotensin II receptors in the late gestation fetus | Q69633333 | ||
| Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat | Q70070620 | ||
| The interaction of insulin and angiotensin II on the regulation of human neuroblastoma cell growth | Q70644038 | ||
| Stimulatory effect of angiotensin II on the proliferation of mouse spleen lymphocytes in vitro is mediated via both types of angiotensin II receptors | Q72265454 | ||
| Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril | Q72525623 | ||
| Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats | Q72710459 | ||
| The cardiac renin-angiotensin system in STZ-induced diabetes | Q72717655 | ||
| Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone | Q72819723 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 418-425 | |
| P577 | publication date | 1996-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure | |
| P478 | volume | 98 |
| Q77550177 | "The road not taken": role of angiotensin II type 2 receptor in pathophysiology |
| Q90443077 | A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril |
| Q24634320 | A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy |
| Q37269304 | A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH. |
| Q30434317 | ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development |
| Q41819451 | AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation |
| Q37598488 | Adapter proteins and promoter regulation of the angiotensin AT2 receptor--implications for cardiac pathophysiology |
| Q37600856 | Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors? |
| Q35045801 | Angiotensin AT2 receptors: cardiovascular hope or hype? |
| Q42518248 | Angiotensin II AT(2) receptor inhibits smooth muscle cell migration via fibronectin cell production and binding |
| Q42439825 | Angiotensin II AT1 and AT2 Receptors Contribute to Maintain Basal Adrenomedullary Norepinephrine Synthesis and Tyrosine Hydroxylase Transcription |
| Q48317328 | Angiotensin II Type 2 Receptor Deficiency Exacerbates Heart Failure and Reduces Survival After Acute Myocardial Infarction in Mice |
| Q35085406 | Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats |
| Q33848631 | Angiotensin II attenuates renal cortical cyclooxygenase-2 expression |
| Q39973660 | Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells |
| Q73683739 | Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy |
| Q77687808 | Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells |
| Q46103013 | Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes. |
| Q42987208 | Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase |
| Q37339329 | Angiotensin II type-2 receptor-specific effects on the cardiovascular system |
| Q34555180 | Angiotensin II-mediated signal transduction pathways. |
| Q34268762 | Angiotensin and its AT2 receptor: new insights into an old system |
| Q51684297 | Blood pressure, arterial stiffness and endogenous lithium clearance in relation to AGTR1 A1166C and AGTR2 G1675A gene polymorphisms. |
| Q42469011 | Ca2+ mobilization in adult rat cardiomyocytes by angiotensin type 1 and 2 receptors |
| Q41682196 | Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance |
| Q44851212 | Changing dietary sodium alters the chronic cardiovascular effects of losartan in rats |
| Q77582102 | Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan |
| Q43640230 | Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. |
| Q47617969 | Dose-dependent inhibitory effects of angiotensin II on visual responses of the rat superior colliculus: AT1 and AT2 receptor contributions |
| Q34981356 | Drugs targeting the renin-angiotensin-aldosterone system |
| Q44390736 | Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats |
| Q36100744 | Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes |
| Q39737596 | Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis |
| Q28348557 | Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin |
| Q36894216 | Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q35872512 | Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic hernia |
| Q44356539 | Maternal High-Fat Diet Causes a Sex-Dependent Increase in AGTR2 Expression and Cardiac Dysfunction in Adult Male Rat Offspring |
| Q52170561 | Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. |
| Q35046512 | Molecular mechanisms of angiotensin II-induced vascular injury. |
| Q74506097 | N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor |
| Q30830224 | Ontogeny and regulation of the AT1 and AT2 receptors in the ovine fetal adrenal gland |
| Q34038063 | Optimal strategies for preventing progression of renal disease: should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together? |
| Q43106907 | Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma. |
| Q36893345 | Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension |
| Q37600876 | Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors |
| Q34297736 | Protection against ischemia: a physiological function of the renin-angiotensin system |
| Q36067015 | Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage |
| Q35791973 | Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin |
| Q38346586 | SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension |
| Q38693277 | Salt, Angiotensin II, Superoxide, and Endothelial Function |
| Q33826656 | Signal transduction from the angiotensin II AT2 receptor |
| Q73134077 | Signaling Mechanism of the AT2 Angiotensin II Receptor: Crosstalk between AT1 and AT2 Receptors in Cell Growth |
| Q33710484 | Special considerations in the therapy of diabetic hypertension |
| Q28364369 | Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors |
| Q33680652 | The AT2 receptor: fact, fancy and fantasy |
| Q37622575 | The angiotensin II type 2 receptor in cardiovascular disease |
| Q87255898 | The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke |
| Q43907226 | The involvement of AT(2)-receptor in the antithrombotic effect of losartan in renal hypertensive rats. |
| Q84968401 | The role of repeatedly heated soybean oil in the development of hypertension in rats: association with vascular inflammation |
| Q34075171 | Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes |
| Q39214578 | Therapeutic targets of renin-angiotensin system in ocular disorders |
| Q26774561 | Vascular endothelial dysfunction and pharmacological treatment |
| Q47752119 | Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice |
Search more.